News

The Alliance for Children’s Therapeutics (ACT) is testing a new drug candidate, called dalazatide (formerly ShK-186), that would potentially be a safer, more effective treatment for a variety of autoimmune diseases that affect millions of people worldwide.


8.2016

6.16.2016

6.10.2016

11.23.15

11.10.15

10.26.15

9.21.15

6.17.15

5.5.15

2.18.15

1.20.15

11.18.14

11.06.14

6.12.14

6.11.14

YOUR SUPPORT HELPS
CHILDREN AND TEENS IN NEED.

Your support propels research that could revolutionize treatment for lupus nephritis and other autoimmune diseases.

Our Affiliates

Seattle Children's Hospital Research Foundation
Kineta - Innovation from Within KPI Therapeutics